In agreement with the reduced levels of sphingolipid metabolites upon fascin knockdown in the current study, we have previously shown suppressed activation of the NF-κB signaling pathway and decreased migration and invasion of fascin knockdown breast cancer cells [14]. The gene discussed is FSCN1; the disease is breast carcinoma.